Navigation Links
Chemstrip Micral

ProductsChemstrip Micral
Company Roche Diagnostics
Item Chemstrip Micral
Features 
  • A fast, easy, one-minutes test to detect subclinical nephropathy
  • In-office testing
  • Proven accuracy compared to radioimmunoassay
  • Long- and short-term cost savings
  • Increased patient and physician satisfaction
Description Chemstrip Micral test strips are an optically read immunoassay to detect albumin in urine samples. When the test strip is dipped into a urine sample, urine passes via a wick fleece into the conjugate fleece. Any albumin present in the sample binds itself specifically to the gold-labeled antibodies.
Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. Chemstrip 101 Urine Analyzer
Breaking Medicine News(10 mins):Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 3Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 4Health News:Zogenix Increases Series B Preferred Stock Financing to $71 Million, Raising $35 Million in Second Tranche 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 3
Other Medicine News:Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 2Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 3Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 4Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 5Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 6Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 7Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 8Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 9Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 10Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 11Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 12Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 13Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 14Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 15Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 16Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 17Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 18Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 19Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 20Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 21Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 22Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 23Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 24Health News:Schering-Plough Reports Financial Results for Third Quarter of 2008 25Health News:Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks 2Health News:Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks 3Health News:Physician Dispensing Wins In A Landslide Majority Of Enhancing Patient Experience 2Health News:Physician Dispensing Wins In A Landslide Majority Of Enhancing Patient Experience 3Health News:Healthcare Staffing Company, Medical Solutions Now Offers More Than Just Cash as Part of its Referral Rewards Program 2Health News:Bend Research Offers Broad Access to Drug-Delivery Solutions 2Health News:HIV Can Re-Emerge From a Single Cell 2
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 1Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 2Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 3Say Cheese With Milk 47498 1Say Cheese With Milk 47498 2Say Cheese With Milk 47498 3Say Cheese With Milk 47498 4Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 1Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 2Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 3